Filing Details
- Accession Number:
- 0001179110-11-006671
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-04-19 19:21:02
- Reporting Period:
- 2011-04-18
- Filing Date:
- 2011-04-19
- Accepted Time:
- 2011-04-19 19:21:02
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 856982 | Merit Medical Systems Inc | MMSI | Surgical & Medical Instruments & Apparatus (3841) | 870447695 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1192954 | J James Ellis | 1600 W. Merit Parkway South Jordan UT 84095 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, No Par Value | Acquisiton | 2011-04-18 | 15,000 | $13.81 | 19,251 | No | 4 | M | Direct | |
| Common Stock, No Par Value | Acquisiton | 2011-04-18 | 15,000 | $11.52 | 34,251 | No | 4 | M | Direct | |
| Common Stock, No Par Value | Disposition | 2011-04-18 | 30,000 | $22.36 | 4,251 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Nonqualified stock options (rights to buy) | Disposition | 2011-04-18 | 15,000 | $0.00 | 15,000 | $13.81 |
| Common Stock | Nonqualified stock options (rights to buy) | Disposition | 2011-04-18 | 15,000 | $0.00 | 15,000 | $11.52 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2004-06-10 | 2014-06-10 | No | 4 | M | Direct |
| 0 | 2006-05-25 | 2013-05-25 | No | 4 | M | Direct |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | Nonqualified stock options (rights to buy) | $21.67 | 2003-12-13 | 2013-12-13 | 15,000 | 15,000 | Direct |
| Common Stock | Nonqualified stock options (rights to buy) | $14.26 | 2005-05-25 | 2015-05-25 | 15,000 | 15,000 | Direct |
| Common Stock | Nonqualified stock options (rights to buy) | $12.13 | 2008-06-27 | 2014-06-27 | 15,000 | 15,000 | Direct |
| Common Stock | Nonqualified stock options (rights to buy) | $14.41 | 2009-05-21 | 2015-05-21 | 15,000 | 15,000 | Direct |
| Common Stock | Nonqualified stock options (rights to buy) | $17.28 | 2010-09-26 | 2016-09-26 | 20,000 | 20,000 | Direct |
| Common Stock | Nonqualified stock options (rights to buy) | $16.45 | 2011-06-25 | 2017-06-25 | 20,000 | 20,000 | Direct |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 2013-12-13 | 15,000 | 15,000 | Direct |
| 2015-05-25 | 15,000 | 15,000 | Direct |
| 2014-06-27 | 15,000 | 15,000 | Direct |
| 2015-05-21 | 15,000 | 15,000 | Direct |
| 2016-09-26 | 20,000 | 20,000 | Direct |
| 2017-06-25 | 20,000 | 20,000 | Direct |
Footnotes
- Become exercisable in equal annual installments of 20% commencing 6/27/2008.
- Become exercisable in equal annual installments of 20% commencing 5/21/2009.
- Become exercisable in equal annual installments of 20% commencing 9/26/2010.
- Become exercisable in equal annual installments of 20% commencing 6/25/2011.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.25 to $22.40, inclusive. The reporting person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
Billionaire Hedge Funds
